Cargando…
Novel Drug Candidates Improve Ganglioside Accumulation and Neural Dysfunction in GM1 Gangliosidosis Models with Autophagy Activation
GM1 gangliosidosis is a lysosomal storage disease caused by loss of lysosomal β-galactosidase activity and characterized by progressive neurodegeneration due to massive accumulation of GM1 ganglioside in the brain. Here, we generated induced pluripotent stem cells (iPSCs) derived from patients with...
Autores principales: | Kajihara, Ryutaro, Numakawa, Tadahiro, Odaka, Haruki, Yaginuma, Yuji, Fusaki, Noemi, Okumiya, Toshika, Furuya, Hirokazu, Inui, Seiji, Era, Takumi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7220856/ https://www.ncbi.nlm.nih.gov/pubmed/32302553 http://dx.doi.org/10.1016/j.stemcr.2020.03.012 |
Ejemplares similares
-
Biochemical Correction of GM2 Ganglioside Accumulation in AB-Variant GM2 Gangliosidosis
por: Deschenes, Natalie M., et al.
Publicado: (2023) -
Sialidase NEU3 action on GM1 ganglioside is neuroprotective in GM1 gangliosidosis
por: Allende, Maria L., et al.
Publicado: (2023) -
Pre-diagnosing and managing patients with GM1 gangliosidosis and related disorders by the evaluation of GM1 ganglioside content
por: Tonin, Rodolfo, et al.
Publicado: (2019) -
Characterization of glycan substrates accumulating in GM1 Gangliosidosis
por: Lawrence, Roger, et al.
Publicado: (2019) -
Neurotrophins and Other Growth Factors in the Pathogenesis of Alzheimer’s Disease
por: Numakawa, Tadahiro, et al.
Publicado: (2023)